---
figid: PMC11117114__etm-28-01-12565-g02
pmcid: PMC11117114
image_filename: PMC11117114__etm-28-01-12565-g02.jpg
figure_link: /pmc/articles/PMC11117114/figure/F3/
number: Figure 3
figure_title: TXNIP/NLRP3 pathway mediates the effects of vitamin D3 in renal tubules
  Expression of (A) NLRP3 and (B) TXNIP detected by reverse transcription-quantitative
  PCR and (C) western blotting.
caption: TXNIP/NLRP3 pathway mediates the effects of vitamin D3 in renal tubules Expression
  of (A) NLRP3 and (B) TXNIP detected by reverse transcription-quantitative PCR and
  (C) western blotting. Protein expression levels of (D) NLRP3 and (E) TXNIP. (F)
  Immunohistochemical analysis of expression of (G) TXNIP and (H) NLRP3. Scale bar,
  50 µm. Magnification, x400. n=6. **P<0.01, ***P<0.001. TXNIP, thioredoxin interacting
  protein; VD3, vitamin D3; STZ, streptozotocin; IOD, integrated Optical Density
article_title: 'Therapeutic potential of vitamin D3 in mitigating high glucose‑induced
  renal damage: Mechanistic insights into oxidative stress inhibition and TXNIP/NLRP3
  signaling pathway blockade'
citation: Guanqing Li, et al. Exp Ther Med. 2024 Jul;28(1).
year: '2024'
pub_date: 2024-7-
epub_date: 2024-5-09
doi: 10.3892/etm.2024.12565
journal_title: Experimental and Therapeutic Medicine
journa_nlm_ta: Exp Ther Med
publisher_name: D.A. Spandidos
keywords:
- diabetic nephropathy
- oxidative stress
---
